or Amgen's Nplate (romiplostim). The drug has been available to NHS patients in Scotland since early 2021. Grifols – a Barcelona-based specialist in plasma-based therapies – said today that ...
and Amgen’s injectable Nplate (romiplostim) in the ITP indication. Doptelet is claimed to have a cleaner clinical profile compared to Promacta, lacking the dietary restrictions, drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback